BTCC / BTCC Square / coincentral /
Cathie Wood Bets Big on Roblox, Dumps Meta Platforms in Bold Portfolio Shift

Cathie Wood Bets Big on Roblox, Dumps Meta Platforms in Bold Portfolio Shift

Published:
2026-01-07 09:39:11
8
3

Cathie Wood's ARK Invest just made a seismic trade—loading up on Roblox while cutting Meta Platforms loose. It's a move that screams conviction in the virtual future over the social media giant.

Why Roblox Over Meta?

Wood's team is chasing the metaverse's pure-play engine. Roblox isn't just a game; it's a creator economy on steroids—a digital sandbox where users build, socialize, and spend. Meta? Still wrestling with an identity crisis between ads, hardware, and Zuckerberg's virtual horizon.

The Numbers Tell the Story

ARK scooped up a hefty chunk of Roblox shares across several funds. The exact figures from the filings show a clear pivot. Meanwhile, Meta got the axe—a significant reduction in position size. No half-measures here.

A Cynical Take on Wall Street's Whims

Let's be real—this is the same street that once thought pet food dot-coms were a solid investment. Today's visionary bet is tomorrow's 'what were we thinking?' footnote. But Wood's track record of going big on disruption demands attention, even from the skeptics.

The Bottom Line

This isn't a tweak. It's a statement. ARK is betting the virtual worlds built by users will outlast and outperform the ad-driven empires of today. One thing's for sure: when Cathie Wood moves, the market watches—and the debate over the next digital frontier just got louder.

TLDR

  • Cathie Wood’s ARK ETFs bought 169,130 Roblox shares worth $13.7 million on January 6, 2026
  • ARK sold 19,316 Meta Platforms shares valued at $12.7 million across multiple ETFs
  • ARK purchased 39,296 Kodiak AI shares worth $409,000 through its robotics ETF
  • ARK reduced biotech holdings by selling $1.8 million in Guardant Health and $568,000 in Ionis Pharmaceuticals
  • The trades show ARK’s shift toward gaming and AI companies while reducing exposure to Meta and healthcare stocks

Cathie Wood’s ARK Invest made several portfolio changes on January 6, 2026, with major moves in Roblox and Meta Platforms. The trades revealed a continued focus on gaming and autonomous technology while scaling back positions in social media and biotech.

ARK purchased 169,130 shares of Roblox Corp across three of its ETFs. The buying spanned the ARK Innovation ETF, ARK Next Generation Internet ETF, and ARK Fintech Innovation ETF. The total purchase value reached $13.7 million.


RBLX Stock Card
Roblox Corporation, RBLX

The Roblox purchase builds on previous investments in the gaming platform. ARK has shown consistent interest in the company over recent trading sessions. The online gaming platform remains part of ARK’s growth strategy.

On the selling side, ARK reduced its Meta Platforms position. The firm sold 19,316 shares across the same three ETFs used for the Roblox purchase. The Meta sale totaled $12.7 million in value.

ARK Adds to AI and Robotics Holdings

The Meta sale continues a pattern of reduced exposure to the social media company. ARK has been trimming its Meta stake in multiple recent trading sessions. The selling trend suggests a shift in Wood’s outlook for the stock.

ARK also increased its position in Kodiak AI. The autonomous driving technology company saw purchases through the ARK Autonomous Technology & Robotics ETF. ARK bought 39,296 shares of Kodiak AI for approximately $409,000.

The Kodiak AI purchase follows recent accumulation in the stock. ARK has been building its position in the autonomous driving company over several days. The moves reflect Wood’s continued interest in AI and robotics sectors.

Healthcare Holdings Face Reductions

ARK reduced two biotech positions on Tuesday. The firm sold 17,613 shares of Guardant Health through its ARK Genomic Revolution ETF. The sale was worth around $1.8 million.

ARK also cut its stake in Ionis Pharmaceuticals. The firm sold 7,228 shares valued at roughly $568,000. Both sales came exclusively through the genomics-focused ETF.

The biotech names Guardant Health and Ionis also have Strong Buy ratings from analysts. However, their projected upside is lower compared to the technology stocks. The ARK trades were published in the firm’s daily trade filings for January 6, 2026.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.